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Ovarian cancer is the leading cause of death from
gynaecological malignancy in developed countries.
Synchronous endometrioid endometrial and ovarian
cancer in patients appears with different clinical
characteristics compared to patients with isolated
endometrial cancer. A 34-year-old woman with lower
abdominal pain of 1 year duration presented at the
emergency department. On gynaecological examination,
she had a left and midline pelvic mass. A transvaginal
ultrasound showed it to be a complex hypervascularised
mass, with cystic and solid components on left adnexal
region. Ectopic pregnancy and pelvic inﬂammatory
disease were excluded. Serum levels of tumour marker
CA125 and ROMA were increased. The MR showed a
complex mass, suggestive of primary fallopian tube or
ovarian tumour. The patient underwent a total
abdominal hysterectomy, bilateral salpingo-
oophorectomy, pelvic and para-aortic lymph node
dissection and subcolonic omentectomy. Histopathology
revealed a synchronous endometrioid endometrial and
ovarian cancer.
BACKGROUND
Ovarian cancer causes around 15 520 deaths annu-
ally in the USA. It is the ﬁfth most lethal malig-
nancy in women and the leading cause of death
from gynaecological cancer in developed countries.
However, it is still relatively uncommon in develop-
ing countries.1
More than 70% have a late-stage diagnosis con-
tributing to the high mortality of ovarian cancer.2
Regarding histological type, over 90% of all
ovarian cancers are epithelial, and among these,
16–25% are endometrioid carcinomas.3
The aetiology of synchronous endometrioid
endometrial and ovarian cancer has not yet been
clariﬁed. Several theories have been proposed. The
theory of extended or secondary Müllerian system
explains the development of primary carcinomas in
multiple sites under the assumption that the
ovarian epithelium, fallopian tube, uterine corpus
and cervix will behave as a unit.4 5 Furlan, in 2006,
provided a molecular insight and suggested that
these tumours “could be the result of either inde-
pendent molecular events affecting multiple cells
separately under the action of a common carcino-
genic agent, or one molecular event in a single
clonal progenitor that gives rise to multiple foci of
tumourigenesis via mechanisms of widespread
clonal expansion.”6
Tobacco use and endometriosis may contribute to
its aetiology as opposed to obesity and oestrogen
excess.7 Regarding endometriosis, two theories
support this relation: (1) a potential direct malignant
transformation on endometriotic implants, and (2)
the idea that endometriosis and cancer have many
predisposing factors (environmental, immunological,
hormonal and genetic) in common.8
CASE PRESENTATION
A 34-year-old woman (gravida 1, para 1) presented
to the emergency department with lower abdom-
inal pain for the past year. Her medical and family
histories were unremarkable, namely for colon and/
or endometrial cancer. On gynaecological examin-
ation, the patient appeared with a painful left and
midline pelvic mass.
INVESTIGATIONS
Pelvic ultrasound examination identiﬁed a complex
hypervascularised mass, with cystic and solid
Figure 1 Pelvic ultrasound—cystic and solid
components.
Figure 2 Pelvic ultrasound—complex hypervascularised
mass.
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components measuring 8×6×4 cm on the left adnexal region
(ﬁgures 1 and 2).
Pregnancy and pelvic inﬂammatory disease were excluded by
laboratory analysis.
Serum levels of tumour marker CA125 and ROMA were
increased (122 U/mL (<35 U/mL) and 66% (<7.5%), respect-
ively). The abdomen and pelvic MRI showed a heterogeneous
mass, suggestive of primary fallopian tube or ovarian tumour
without evidence of distant involvement (ﬁgure 3).
The patient underwent an exploratory laparotomy, which
revealed an ovarian tumour. An intraoperative examination was
performed, and was highly suggestive of malignancy. A total
abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic
and para-aortic lymph node dissection and subcolonic omen-
tectomy were conducted (ﬁgure 4).
Histopathology revealed a synchronous endometrioid endo-
metrial and ovarian cancer.
DIFFERENTIAL DIAGNOSIS
Lower abdominal pain and an adnexal mass in a 34-year-old
woman are highly suggestive of ectopic pregnancy or pelvic
inﬂammatory disease. In the present case, the former hypothesis
was not compatible with the long lasting symptoms. Both
hypotheses were ruled out by laboratory tests and transvaginal
ultrasound. Ultrasonography ﬁndings were in favour of an
ovarian/fallopian tumour. Tumour markers (CA125 and ROMA)
were requested and their values were increased. MRI reinforced
the hypothesis of a tumour deriving from the fallopian tube or
an ovarian tumour.
TREATMENT
An exploratory laparotomy was decided on. An approximate
7 cm left ovarian mass was found. As the intraoperative examin-
ation was highly suggestive of malignancy, a total abdominal
hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-
aortic lymph node dissection and subcolonic omentectomy were
conducted. The histological examination revealed a gastrointes-
tinal (GI) endometrioid ovarian cancer and a GI endometrioid
endometrial cancer. The peritoneal wash cytology showed no
tumour cells and no metastases were found.
OUTCOME AND FOLLOW-UP
The patient had an uncomplicated postoperative course. Her
case was discussed in a multidisciplinary board meeting and the
consensus was for clinical, tumour marker and imaging surveil-
lance. The surgery was performed 5 months ago.
DISCUSSION
A diagnosis of concomitant endometrioid endometrial and
ovarian cancer is rare, particularly at the age of 34 years.
Exclusion of other more common causes of pelvic/abdominal
pain is, therefore, necessary. Ultrasonography was the mainstay
of diagnosis, prompting further examinations.
Coexistence of endometrial carcinoma and ovary carcinoma
occurs in about 5% of patients with endometrial cancer and
10% of patients with ovarian cancer.9
Some authors have suggested that these tumours are more
common in younger patients, can be diagnosed at an early stage
and are associated with low-grade disease; however, there is
some controversy regarding the behaviour of these tumours.10–12
A ﬁnal diagnosis of synchronous ovarian and endometrial
cancer requires ruling out two other possible diagnoses: primary
endometrial cancer with ovarian metastasis or primary ovarian
cancer with endometrial metastasis.13 Ulbright and Roth, in
1985, proposed histological criteria to distinguish synchronous
primary cancers from metastatic lesions.14 These criteria were
revised in 1998 by Scully et al.15 Since then, several authors
have proposed methods for molecular analysis, but no consensus
has been reached yet.13
A subset of endometrioid ovarian cancers in patients under
the age of 53 years can be associated with loss of mismatch
Figure 3 MRI—complex tumoural
mass.
Figure 4 Ovarian tumour.
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repair genes expression. In these patients, the risk of a second
synchronous or metachronous primary malignancy is higher.16
Immunohistochemical staining for mismatch repair genes
expression is recommended for all women under 53 years of
age with endometrioid or clear cell carcinomas of the ovary.
Following recommendations, immunohistochemistry studies are
underway in our patient.16
At the time of publication results are pending.
Learning points
▸ Endometrioid and ovarian cancer is rare, particularly in a
34-year-old woman.
▸ Its diagnosis is difﬁcult and requires a high level of
suspicion, after excluding more frequent causes of lower
abdominal pain in this age group.
▸ In this patient, an endometrial cancer diagnosis was
unexpected. However, the early diagnosis and treatment led
to a better outcome.
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